EverSource Wealth Advisors’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31K Buy
1,836
+1,101
+150% +$3.03K ﹤0.01% 3086
2026
Q1
$985 Buy
735
+710
+2,840% +$1.42K ﹤0.01% 3858
2025
Q4
$61 Sell
25
-280
-92% -$1.22K ﹤0.01% 4156
2025
Q3
$2.05K Sell
305
-144
-32% -$940 ﹤0.01% 3505
2025
Q2
$2.64K Buy
449
+247
+122% +$1.61K ﹤0.01% 3407
2025
Q1
$1.7K Buy
202
+198
+4,950% +$1.78K ﹤0.01% 2997
2024
Q4
$30 Buy
+4
New +$27 ﹤0.01% 3684
2023
Q3
Sell
-39
Closed -$998 2658
2023
Q2
$998 Buy
+39
New +$1.01K ﹤0.01% 2228

Other funds holding TMCI

EverSource Wealth Advisors's TMCI Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Treace Medical Concepts (TMCI) stake by 150% in Q2 2026, buying an estimated $3.03K and bringing the position to 1,836 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

EverSource Wealth Advisors first reported a position in TMCI in Q2 2023 and has held it in 8 quarters since. 23 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • EverSource Wealth Advisors held 1,836 shares of Treace Medical Concepts worth $7.31K as of Q2 2026.
  • EverSource Wealth Advisors bought 1,101 Treace Medical Concepts shares in Q2 2026, an estimated $3.03K.
  • Treace Medical Concepts made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3086 holding.
  • EverSource Wealth Advisors first reported a position in Treace Medical Concepts in Q2 2023 and has held it in 8 quarters since.
  • 23 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.